Placebo group:None

8 trials

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, The First Affiliated Hospital of Wenzhou Medical University, The First People' Hospital of Jiashan, Provincial Hospital Affiliated to Shandong First Medical University, Beijing An Ding Hospital, Capital Medical University

Conditions

BronchiectasisCoronary heart disease with renal insufficiencyMajor depressive disorderModerate to severe chronic obstructive pulmonary disease (COPD)Motor symptoms including tremor, rigidity, bradykinesia and postural instability, as well as sleep disorders, olfactory dysfunction, autonomic nervous system dysfunction, cognitive and psychiatric disorderscardiac diseasesgestational diabetes mellitusseptate uterus

Early Phase 1

A prospective, randomized, controlled, multicenter study on the prevention of adhesion after transcervical resection of septum

RecruitingChiCTR2000032061

Peking Union Medical College Hospital, Chinese Academy of Medical Sciencesseptate uterus

Start: 2020-05-01Updated: 2022-05-09

Phase 2

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase ?b Clinical Trial to Evaluate the Efficacy and Safety of Oral VG081821AC Tablets as Monotherapy (without concomitant levodopa administration) in Patients with Early-to-Moderate Parkinson’s Disease

Active, not recruitingChiCTR2600127436

Capital Medical University Xuanwu HospitalMotor symptoms including tremor, rigidity, bradykinesia and postural instability, as well as sleep disorders, olfactory dysfunction, autonomic nervous system dysfunction, cognitive and psychiatric disorders

Start: 2026-07-01Updated: 2026-07-13

Phase 3

A randomized, double-blinded, placebo-controlled phase III clinical trial, to evaluate the safety and efficacy of 611(Recombinant anti-IL-4Ra humanized monoclonal antibody) in Chinese adults with moderate to severe chronic obstructive pulmonary disease (COPD)

Active, not recruitingChiCTR2500104536

Shenzhen People's HospitalModerate to severe chronic obstructive pulmonary disease (COPD)

Start: 2025-07-15Updated: 2025-06-24

Phase 4

A randomized controlled study of comparing the effect of two azithromycin regimens in reducing exacerbation of non-cystic fibrosis

RecruitingChiCTR2100052906

The First People' Hospital of JiashanBronchiectasis

Start: 2022-01-01Updated: 2022-08-23

Unknown Phase

Clinical research on spironolactone in the treatment of coronary heart disease with renal insufficiency based on heart and kidney remodeling

RecruitingChiCTR2100042510

The First Affiliated Hospital of Wenzhou Medical UniversityCoronary heart disease with renal insufficiency

Start: 2021-03-01Updated: 2021-05-03

Effect of perioperative administration of nesiritide on clinical outcome after cardiac surgery

Active, not recruitingChiCTR2300067794

Provincial Hospital Affiliated to Shandong First Medical Universitycardiac diseases

Start: 2023-02-01Updated: 2023-05-15

Study on the Brain Mechanisms of (R)-Ketamine Hydrochloride Nasal Spray in the Treatment of Patients with Treatment-Resistant Depression

Active, not recruitingChiCTR2500104532

Beijing An Ding Hospital, Capital Medical UniversityMajor depressive disorder

Start: 2025-06-20Updated: 2025-06-24

Study on the Effects of Probiotic Intervention during Pregnancy on the Growth and Development and Immune Function of Offspring of High-risk Pregnant Women with Gestational Diabetes Mellitus

Active, not recruitingChiCTR2600124134

Children's Hospital of Nanjing Medical Universitygestational diabetes mellitus

Start: 2026-05-10Updated: 2026-05-11

Related Papers

Daily versus three-times-weekly azithromycin in Chinese patients with non-cystic fibrosis bronchiectasis: protocol for a prospective, open-label and randomised controlled trial

BMJ Open2022-07-012 citations